Search Results
Debate: Is circulating tumor DNA ready to guide adjuvant therapy in colon cancer? - Yes
DYNAMIC - Circulating Tumor DNA to decide Adjuvant Chemo in Stage II Colon Cancer | LEVEL - HARD
Circulating Tumor DNA (ctDNA) to Reshape Clinical Trial Design in Early Stage Cancers
FOLFOX Alone or Combined with Atezolizumab as Adjuvant Therapy in Stage III Colon Cancer (ATOMIC)
Dr Chris Jackson on the impact of CtDNA technology
Colon Cancer | 2022 OneOncology Conference
Practice-changing research in GI cancer
Debate: Are novel targets such as HER2 ready for prime time in colorectal cancer? - No
Is my treatment working? Using ctDNA to optimize the management of colorectal cancer
Efficacy of Adjuvant Therapy in Stage II Colon Cancer
S2 Episode 1: Tumor Trash or Treasure? Liquid Biopsy for Colorectal Cancer
Dr. Grady on Circulating Tumor Cells in Pancreatic Cancer